BevacizumabWorsened hypertension: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1776卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70257-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：99 / 99

相关论文

共 50 条

[41] Loteprednol-etabonateIntraocular hypertension : 2 case reports
Reactions Weekly, 2024, 2019 (1) : 253 - 253
[42] Bevacizumab/nivolumabThrombotic microangiopathy and hypertension: 2 case reports
Reactions Weekly, 2023, 1949 (1) : 104 - 104
[43] Bevacizumab/octreotideDiarrhoea, hypertension and epistaxis: 2 case reports
Reactions Weekly, 2020, 1792 (1) : 54 - 54
[44] DoxycyclineFirst report of intracranial hypertension: 2 case reports
Reactions Weekly, 2003, 944 (1) : 7 - 8
[45] Carboplatin/thiotepaPulmonary arterial hypertension: 2 case reports
Reactions Weekly, 2021, 1881 (1) : 64 - 64
[46] MetamfetamineWorsening of pulmonary arterial hypertension: 2 case reports
Reactions Weekly, 2021, 1862 (1) : 281 - 281
[47] Zoledronic acidAtrial fibrillation and hypertension: 2 case reports
Reactions Weekly, 2017, 1633 (1) : 716 - 716
[48] KetamineAspiration, agitation and pulmonary hypertension: 2 case reports
Reactions Weekly, 2021, 1854 (1) : 204 - 204
[49] Prednisolone-acetateOcular hypertension: 2 case reports
Reactions Weekly, 2020, 1810 (1) : 178 - 178
[50] SomatropinPapilloedema and benign intracranial hypertension: 2 case reports
Reactions Weekly, 2017, 1660 (1) : 290 - 290

← 1 2 3 4 5 →